Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Zenobia Therapeutics
company
About
Zenobia Therapeutics is a focus on discovering treatments for neurodegenerative diseases using fragment-based lead discovery.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $225K
- Industries
- Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2008
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Zenobia Therapeutics was founded in 2008 with a focus on discovering treatments for neurodegenerative diseases using fragment-based lead discovery. In 2014, Zenobia added a products division, Zenobia Fragments that supplies products and services to support fragment-based lead discovery.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$225K
Zenobia Therapeutics has raised a total of
$225K
in funding over 2 rounds. Their latest funding was raised on
Jun 28, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 28, 2019 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Zenobia Therapeutics is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
